n 0437, (-)-isomer has been researched along with Disruptive, Impulse Control, and Conduct Disorders in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Calandra-Buonaura, G; Contin, M; Cortelli, P; De Massis, P; Guarino, M; Lopane, G; Marini, L; Mohamed, S; Persichella, C; Sambati, L; Sermi, S | 1 |
| Anheim, M; Grillon, A; Lipsker, D; Moegle, C; Velter, C | 1 |
| Alonso-Canovas, A; Garcia-Ruiz, PJ; Herranz Barcenas, A; Mahillo Fernandez, I; Martinez Castrillo, JC; Mata, M; Olmedilla Gonzalez, N; Sanchez Alonso, P; Vela, L | 1 |
| Antonini, A; Asgharnejad, M; Bauer, L; Boroojerdi, B; Chaudhuri, KR; Grieger, F; Weintraub, D | 1 |
| Hinnell, C; Hulse, N; Martin, A; Samuel, M | 1 |
| Baumann, CR; Eisele, G; Gantenbein, AR; Schreglmann, SR | 1 |
1 review(s) available for n 0437, (-)-isomer and Disruptive, Impulse Control, and Conduct Disorders
| Article | Year |
|---|---|
Impulse control disorder related behaviours during long-term rotigotine treatment: a post hoc analysis.
Topics: Aged; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Female; Humans; Male; Middle Aged; Parkinson Disease; Tetrahydronaphthalenes; Thiophenes | 2016 |
6 other study(ies) available for n 0437, (-)-isomer and Disruptive, Impulse Control, and Conduct Disorders
| Article | Year |
|---|---|
Screening for impulse control disorders in Parkinson's disease and dopamine agonist use: a study of pharmacokinetic and psychological risk factors.
Topics: Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Humans; Parkinson Disease; Pramipexole; Prospective Studies; Risk Factors | 2023 |
Impulse control disorder-linked hypersexuality complicated by disseminated gonococcal infection in a patient with Parkinson's disease.
Topics: Amantadine; Apomorphine; Compulsive Behavior; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Female; Gonorrhea; Humans; Levodopa; Middle Aged; Parkinson Disease; Sexual Dysfunctions, Psychological; Tetrahydronaphthalenes; Thiophenes | 2020 |
Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study.
Topics: Administration, Cutaneous; Administration, Oral; Age Factors; Aged; Antiparkinson Agents; Benzothiazoles; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Sex Factors; Tetrahydronaphthalenes; Thiophenes | 2014 |
Transdermal rotigotine in restless legs syndrome: impulse control disorders.
Topics: Administration, Cutaneous; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Humans; Restless Legs Syndrome; Risk Assessment; Risk Factors; Tetrahydronaphthalenes; Thiophenes; Transdermal Patch; Treatment Outcome | 2014 |
Hypersexuality and compulsive over-eating associated with transdermal dopamine agonist therapy.
Topics: Antiparkinson Agents; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Humans; Hyperphagia; Hypokinesia; Male; Parkinson Disease; Sexual Dysfunction, Physiological; Tetrahydronaphthalenes; Thiophenes | 2011 |
Transdermal rotigotine causes impulse control disorders in patients with restless legs syndrome.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Female; Humans; Longitudinal Studies; Male; Middle Aged; Restless Legs Syndrome; Retrospective Studies; Surveys and Questionnaires; Tetrahydronaphthalenes; Thiophenes | 2012 |